The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...

( NewsNation) — New research suggests popular weight loss drugs like Ozempic and Wegovy may affect more than just fat, ...

Veru Inc. ( NASDAQ: VERU) Q3 2025 Earnings Call August 12, 2025 8:00 AM ET K. Gary Barnette - Chief Scientific Officer Michael J. Purvis - Executive VP, General Counsel & Corporate Strategy and ...

Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk recently completed a clinical study ...

A large-scale cohort study has found that GLP-1s, including Ozempic and Wegovy, may be associated with a modestly increased risk of developing diabetic retinopathy. The research, published Aug. 11 in ...

Overview - As demand for GLP-1 drugs continues to skyrocket, federal and state agencies are turning their attention to the GLP-1 ...

Researchers at the University of Utah say new weight loss drugs pose new questions about what happens to muscle mass and ...

In this clip, Elise S. Tremblay, MD, MPH, explores factors behind fluctuations in insulin out-of-pocket costs and highlights the serious health consequences of persistently lower insulin use.

With anti-obesity drugs like semaglutide set to drop in price from a staggering Rs 30,000 to just Rs 3,000 per month, ...

University of Utah-led research found those losing weight with Ozempic also lost about 10% of lean mass, though not ...

Two studies were conducted to verify concerns about diabetic retinopathy that were raised during initial trials of ...

More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...